Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada.

Goeree, Ron; Goeree, Jeff

Goeree, Ron; Goeree, Jeff.

Affiliation

Goeree R; a a Goeree Consulting Limited , Hamilton, Ontario , Canada.
Goeree J; b bProfessor Emeritus , McMaster University , Hamilton, Ontario , Canada.

J Med Econ ; 19(3): 277-91, 2016.

Article in En | MEDLINE | ID: mdl-26535790

Subject(s)

Analgesics, Opioid/economics; Analgesics, Opioid/therapeutic use; Chronic Pain/drug therapy; Constipation/chemically induced; Naloxone/economics; Naloxone/therapeutic use; Narcotic Antagonists/economics; Narcotic Antagonists/therapeutic use; Oxycodone/economics; Oxycodone/therapeutic use; Pain Management/economics; Adult; Canada; Constipation/prevention & control; Cost-Benefit Analysis; Drug Combinations; Female; Humans; Male; Monte Carlo Method; Quality-Adjusted Life Years; Treatment Outcome

Key words

Canada; Chronic pain; Cost-utility analysis; Economic evaluation; Opioid-induced constipation; Oxycodone; Targin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxycodone / Constipation / Chronic Pain / Pain Management / Analgesics, Opioid / Naloxone / Narcotic Antagonists Type of study: Guideline / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Adult / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: J Med Econ Journal subject: SERVICOS DE SAUDE Year: 2016 Document type: Article Affiliation country: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google